Merck
CN
Search Within
文件类型

214-665-1

应用筛选条件
关键词:'214-665-1'
显示 1-26 共 26 条结果 关于 "214-665-1" 范围 技术文档
Product Information Sheet - N1628
# 6641. 2. Brock, in Antibiotics, 1, Gottlieb, D., and Shaw, P. D., eds., Springer-Verlag (New York, NY: 1967), p. 651-665. 3. Ryan, in Antibiotics, 5-pt. 1, Hahn, F. E., ed., Springer-Verlag
Data Sheet - 77237
Obrink, B. et al., Biochem. Biophys. Res. Commun., 77, 665-670 (1977). CHO Membranes Cezanne, L. et al., Biochim. Biophys. Acta, 1112, 205-214 (1992). Lysozomes Lindley, E.R.
XP725 Antibody Number-Lot Number 071M4826
613 614 615 616 637 638 639 640 661 662 663 664 7.5 593 594 595 596 617 618 619 620 641 642 643 644 665 666 667 668 7.6 597 598 599 600 621 622 623 624 645 646 647 648
Percoll - Product Information Sheet
Biophys. Res. Commun., 77, 665-670 (1977). Page 6 of 7 CHO Membranes
Product Information Sheet - P7828
Obrink, B. et al., Biochem. Biophys. Res. Commun., 77, 665-670 (1977). CHO Membranes Cezanne, L. et al., Biochim. Biophys. Acta, 1112, 205- 214 (1992). Lysozomes Lindley, E.R. and Pisoni, R.L., Biochem
Product Information Sheet - P1644
Obrink, B. et al., Biochem. Biophys. Res. Commun., 77, 665-670 (1977). CHO Membranes Cezanne, L. et al., Biochim. Biophys. Acta, 1112, 205- 214 (1992). Lysozomes Lindley, E.R. and Pisoni, R.L., Biochem
Product Information Sheet - P4937
Obrink, B. et al., Biochem. Biophys. Res. Commun., 77, 665-670 (1977). CHO Membranes Cezanne, L. et al., Biochim. Biophys. Acta, 1112, 205- 214 (1992). Lysozomes Lindley, E.R. and Pisoni, R.L., Biochem
Product Information Sheet - E0414
Obrink, B. et al., Biochem. Biophys. Res. Commun., 77, 665-670 (1977). CHO Membranes Cezanne, L. et al., Biochim. Biophys. Acta, 1112, 205- 214 (1992). Lysozomes Lindley, E.R. and Pisoni, R.L., Biochem
PKH Dye Reference Guide
Spielmann R, Boyd FT: Positive selection of growth-inhibitory genes. Cell Growth Differ. 1995; 6: 665-671. 79. Modha J, Kusel JR, Kennedy MW: A role for second messengers in the control of activation-associated
Exploring Akt/mTOR Signaling Using the MILLIPLEX®MAP Akt/mTOR 11-plex Panel
10956 60 967 540 1183 Prostate 143 326 35 ND 176 163 10906 82 345 454 1102 Skeletal Muscle 186 665 38 ND 552 15 6643 12 265 374 636 Testicles 250 108 101 ND 57 52
RISK MITIGATION & QUALITY REQUIREMENTS
OPERATIONAL EXCELLENCE Extractables profiles assessed from multiple lots following BPOG and USP 665 methodologies are provided to support batch-to-batch consistency. BACKHOME Emprove® ProgramContact
Manual Spectroquant Spectrophotometer Pharo 300
before) 665 nm - A(after) 665 nm)*(VExtract/VSam- ple) with: A(before) 665 nm 1st absorbance measurement at 665 nm (before adding the acid) A(after) 665 nm 2nd absorbance measurement at 665 nm (
Manual Spectroquant Spectrophotometer Pharo 100
before) 665 nm - A(after) 665 nm)*(VExtract/VSam- ple) with: A(before) 665 nm 1st absorbance measurement at 665 nm (before adding the acid) A(after) 665 nm 2nd absorbance measurement at 665 nm (
XP725 Antibody List Lot 129K4831
622 Negative Control NA 660 Serine/Threonine Protein Phosphatase 2 A/Bg P5359 665 SH-PTP2 (SHP-2) S3056 670 SIRPa1 (SHPS-1) S1311 684 Sos1 S2937 704 Negative Control NA XP725 Antibody list
XP725 Antibody List Lot 129K4830
622 Negative Control NA 660 Serine/Threonine Protein Phosphatase 2 A/Bg P5359 665 SH-PTP2 (SHP-2) S3056 670 SIRPa1 (SHPS-1) S1311 684 Sos1 S2937 704 Negative Control NA XP725 Antibody list
XP725 Antibody List Lot 089K4791
622 Negative Control NA 660 Serine/Threonine Protein Phosphatase 2 A/Bg P5359 665 SH-PTP2 (SHP-2) S3056 670 SIRPa1 (SHPS-1) S1311 684 Sos1 S2937 704 Negative Control NA XP725 Antibody list
Manual Spectroquant espectrofotometro Pharo 300
29.6 * (A(antes) 665 nm - A(después) 665 nm)*(Vextracto/Vmuestra) con: A(antes) 665 nm Primera medición de la absorbancia a 665 nm (antes de añadir el ácido) A(después) 665 nm Segunda medición
Manual Spectroquant espectrofotometro Pharo 100
29.6 * (A(antes) 665 nm - A(después) 665 nm)*(Vextracto/Vmuestra) con: A(antes) 665 nm Primera medición de la absorbancia a 665 nm (antes de añadir el ácido) A(después) 665 nm Segunda medición
Cytoskeletal Signaling Antibodies, Reagents and Kits
Activation Assay Kit ABA 1 kit 17-218 H-Ras cDNA Allelic Pack TFX 1 kit 17-267 siRNA Ras siRNA/siAb Assay Kit H WB RNAi 1 kit 60-093 siRNA plasmid, pKD-Ras-v1 RNAi 5 µg 62-214 siRNA plasmid
List of Antibodies
d n/d 665 SH-PTP2 (SHP-2) S3056 P y n/d n/d 666 Siah2 S7945 M y y n/d 667 Sin3A, N-terminal S4445 P y y y 668 Sin3A, C-Terminal S6695 P y n/d n/d 669 Sir2S S5313 P n/d y n/d 670 SIRPα1
XP725 Antibody List
808908.1,NP_062284.1 P y y n/d 663 Negative Control 664 SGK S5188 6446 SGK NP_005618.2 P y n/d n/d 665 SH-PTP2 (SHP-2) S3056 5781 PTPN11 NP_002825.3 P y n/d n/d 666 Siah2 S7945 20439, 6478 Siah2,SIAH2
XP725 Antibody List 013M4793
808908.1,NP_062284.1 P y y n/d 663 Negative Control NA 664 SGK S5188 6446 SGK NP_005618.2 P y n/d n/d 665 SH-PTP2 (SHP-2) S3056 5781 PTPN11 NP_002825.3 P y n/d n/d 666 Siah2 S7945 20439, 6478 Siah2,SIAH2
Antibody Sourcebookル Sixth Edition
�9 100 µl €��1 Anti-PARP-1 (197-214) Rabbit pAb ELISA, IB, IC, IF, IP human 5127�8 100 µl €�04 Anti-PARP-1 (Ab-1) Rabbit pAb IB; NOT IP, NOT PS human PC100 100 µg €277 Anti-PARP-1 (Ab-2) Mouse
Halal Certificate
, FG W240001 A50487 HC-23SIJ583 664. GAMMA-DODECALACTONE, NATURAL W240015 C37176 HC-23SIZO18 665. GAMMA-HEPTALACTONE 98%, FCC, FG W253901 A53304 HC-23SII995 666. GAMMA-HEXALACTONE 98%, FCC, FG
Halal Certificate
, FG W240001 A50487 HC-22SISH05 664. GAMMA-DODECALACTONE, NATURAL W240015 C37176 HC-22SI7F39 665. GAMMA-HEPTALACTONE 98%, FCC, FG W253901 A53304 HC-22SIDP17 666. GAMMA-HEXALACTONE 98%, FCC, FG
Manual Spectroquant Fotómetro NOVA 60A
, TC 100616 3,0 – 100,0 mg/l de PO4-P Azul de fosfomolibdeno 214 Fosfatos, TC 100673 3,0 – 100,0 mg/l de PO4-P Azul de fosfomolibdeno 214 Fosfatos, TC (fósforo total) 100673 3,0 – 100,0 mg/l de P Oxidación